Clinical trial
Study of a Pandemic Influenza Vaccine
NCT00136331 · Seqirus, Industry · Completed
Key facts
| NCT number | NCT00136331 |
|---|---|
| Title | Study of a Pandemic Influenza Vaccine |
| Official title | Phase Ia Study of a Pandemic Influenza Vaccine |
| Lead sponsor | Seqirus, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Pandemic influenza vaccine |
| Enrollment | 400 |
| Start date | Oct 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Aug 29, 2005 |
| Last update posted | Jul 19, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: